Preveceutical Med Inc New
(PRVCF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 2 | 1 | 1 | 2 |
| Receivables | 11 | 4 | 4 | 2 | 3 |
| TOTAL | $45 | $53 | $47 | $69 | $53 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | 1 | 1 | 1 |
| Intangibles | 83 | 84 | 87 | 87 | 89 |
| TOTAL | $85 | $85 | $87 | $87 | $90 |
| Total Assets | $130 | $138 | $135 | $156 | $143 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,022 | 2,945 | 2,885 | 2,816 | 2,715 |
| Accounts payable and accrued liabilities | 1,655 | 1,605 | 1,530 | 1,362 | 1,266 |
| TOTAL | $4,677 | $4,550 | $4,415 | $4,178 | $3,980 |
| Non-Current Liabilities | |||||
| Long Term Debt | 45 | 45 | N/A | N/A | N/A |
| TOTAL | $45 | $45 | $N/A | $N/A | $N/A |
| Total Liabilities | $4,721 | $4,595 | $4,415 | $4,178 | $3,980 |
| Shareholders' Equity | |||||
| Common Shares | 14,176 | 14,313 | 14,304 | 14,391 | 14,362 |
| Retained earnings | -21,195 | -21,234 | -21,046 | -20,858 | -20,657 |
| Other shareholders' equity | 2,428 | 2,464 | 2,461 | 2,446 | 2,458 |
| TOTAL | $-4,592 | $-4,457 | $-4,281 | $-4,022 | $-3,837 |
| Total Liabilities And Equity | $130 | $138 | $134 | $156 | $143 |